Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AWK$141.70-1.05(-0.74%)American Water Charitable Foundation Awards $10,000 Grant to Help Heartland Students Build Financial Skills The American Water Charitable Foundation, a philanthropic nonprofit organization established by American Water (NYSE: AWK), and Iowa American Water...[5:57:00 PM ET]HYOR$0.07+0.00(+0.13%)HyOrc Unveils European Expansion Strategy, Targets 150 TPD Waste-to-Methanol Facility in Portugal by 2028[5:53:08 PM ET]AMGN$444.00+4.74(+1.08%)AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS Amgen (NASDAQ: AMGN) today announced the appointment of David W. Gibbs to its Board of Directors, effective immediately. Gibbs will serve on the...[5:52:00 PM ET]PPTA$16.48+0.04(+0.24%)Perpetua Resources Awarded Up to $40 Million in U.S. Army Funding to Advance Domestic Tungsten Supply for American Defense Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") today announced a new 36-month, $40 million ...[5:45:00 PM ET]VLRS$5.89+0.21(+3.70%)Volaris Reports Financial Results for the Third Quarter 2026: $1 Billion Revenue, up 32% YoY[5:30:00 PM ET]BLX$53.37-0.54(-1.00%)BLADEX ANNOUNCES QUARTERLY DIVIDEND PAYMENT FOR THIRD QUARTER 2026 Bladex, Inc. announced today its Board of Directors' approval of a quarterly cash dividend of US$0.6875 per share corresponding to the third quarter...[5:30:00 PM ET]BLX$53.37-0.54(-1.00%)Bladex announces Net Profit of $63.2 Million for the Third Quarter 2026 Bladex, Inc. (NYSE: BLX, or "the Bank"), a Panama-based multinational bank originally established by the central banks of 23 Latin-American and...[5:30:00 PM ET]BLSH$27.60-0.61(-2.16%)Issuer Sponsored Token Coalition gains momentum as QRT, Vertalo and zerohash join[5:30:00 PM ET]AMYZF$0.03-0.00(-0.65%)RecycLiCo Announces Filing and Mailing of Management Information Circular for 2026 Annual General Meeting[5:24:21 PM ET]CERO$0.01+0.00(+25.00%)CERo Therapeutics Announces Activation of the University of California, Davis as a Clinical Trial Site for the Ongoing Phase 1 CERTAIN-T Trial of CER-1236 in Hematologic Malignancies[5:21:39 PM ET]ACNT$13.53-0.41(-2.94%)CORRECTING and REPLACING Ascent Industries Sets Third Quarter 2026 Earnings Conference Call for November 4, 2026, at 5:00 p.m. ET[5:20:00 PM ET]NRG$93.61+1.30(+1.41%)NRG Energy to Report Third Quarter 2026 Financial Results on November 9, 2026[5:17:00 PM ET]TWFG$29.03+0.74(+2.62%)TWFG, Inc. To Announce Third Quarter 2026 Financial Results on Wednesday, November 4, 2026[5:16:14 PM ET]AWK$141.70-1.05(-0.74%)New Jersey American Water and American Water Charitable Foundation Celebrate Completion of Rutgers Weather Station The American Water Charitable Foundation, a philanthropic non-profit organization established by American Water (NYSE: AWK), the largest regulated...[5:15:00 PM ET]VRT$203.52+9.20(+4.74%)Vertiv Simplifies High-Density AI Infrastructure Deployment Across Data Center Environments Vertiv Holdings Co. (NYSE: VRT), a global leader in critical digital infrastructure, today introduced the Vertiv™ SmartIT solution, a pre-engineered...[5:12:00 PM ET]

NYXH · NASDAQ

Nyxoah S.A.

$0.84 +0.01 (+0.67%)

Company overview

Nyxoah S.A. is a medical technology company focused on developing and commercializing solutions for sleep-disordered breathing conditions. The company offers the Genio system, a CE‑marked, patient-centric hypoglossal neurostimulation therapy for treating moderate to severe obstructive sleep apnea. Founded in 2009, Nyxoah is headquartered in Mont-Saint-Guibert, Belgium.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Market cap
$85.5M
Employees
183
Headquarters
Mont-Saint-Guibert
Website
nyxoah.com
CEO
Olivier Taelman
Listed
April 28, 2021
P/E
-0.39
Dividend yield
0.00%

Company financials

Revenue
$16.3M
Gross profit
$7.9M
Operating income
-$86M
EBITDA
-$84.3M
Net income
-$86.1M
EPS
-$2.14
Total assets
$98M
Total debt
$36.2M
Gross margin
48.34%
Net margin
-527.77%
Earnings yield
-254.76%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

0.701.402.092.793.49
NYXH 1D NASDAQ O0.86H0.87L0.80C0.83+0.01 (+1.51%)Vol181.01K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
NYXHNyxoah S.A. Press release Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026 GlobeNewswire
NYXHNyxoah S.A. Press release Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026 GlobeNewswire
NYXHNyxoah S.A. Press release Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 GlobeNewswire
NYXHNyxoah S.A. Stock news Contrasting Nephros (NASDAQ:NEPH) & Nyxoah (NASDAQ:NYXH) Defense World
NYXHNyxoah S.A. Stock news Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market. Seeking Alpha
NYXHNyxoah S.A. Press release Nyxoah Appoints Liam Kelly as Chief Executive Officer GlobeNewswire
NYXHNyxoah S.A. Press release CVRx Appoints John Landry as Chief Financial Officer GlobeNewswire
NYXHNyxoah S.A. Press release Nyxoah Announces Chief Financial Officer Transition GlobeNewswire
NYXHNyxoah S.A. Stock news Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial Zacks Investment Research
NYXHNyxoah S.A. Stock news Nyxoah Annonce l’Implantation du Premier Patient dans BREATHE, l’Étude Post-Approbation Américaine du Système Genio® Globe News Wire
NYXHNyxoah S.A. Press release Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System GlobeNewswire
NYXHNyxoah S.A. Press release Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients GlobeNewswire
NYXHNyxoah S.A. Stock news Nyxoah SA (NYXH) Q2 2026 Earnings Call Transcript Seeking Alpha
NYXHNyxoah S.A. Stock news Nyxoah Q2 Earnings Call Highlights MarketBeat
NYXHNyxoah S.A. Press release Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results GlobeNewsWire
NYXHNyxoah S.A. Press release Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewsWire
NYXHNyxoah S.A. Stock news Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day MarketBeat
NYXHNyxoah S.A. Stock news Nyxoah SA (NYXH) Analyst/Investor Day Transcript Seeking Alpha
NYXHNyxoah S.A. Press release Nyxoah Announces Preliminary Results for the Second Quarter of 2026 GlobeNewsWire
NYXHNyxoah S.A. Press release Information on the total number of voting rights and shares GlobeNewsWire
See more
FAQ

Questions about Nyxoah S.A.

What does Nyxoah S.A. do?
Nyxoah S.A. is a medical technology company focused on developing and commercializing solutions for sleep-disordered breathing conditions. The company offers the Genio system, a CE‑marked, patient-centric hypoglossal neurostimulation therapy for treating moderate to severe obstructive sleep apnea. Founded in 2009, Nyxoah is headquartered in Mont-Saint-Guibert, Belgium.
What is NYXH's market cap?
Nyxoah S.A. (NYXH) is a listed stock with a live quote. The latest market cap on this page is $85.5M.
Where is Nyxoah S.A. headquartered?
Nyxoah S.A. is headquartered in Mont-Saint-Guibert.
How do I get NYXH news from the API?
Call GET /v1/news?tickers=NYXH. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does NYXH news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for NYXH, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the NYXH price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs